Fully underwritten 31 for 47 at 35.8% discount to TERP. Gross proceeds of c. £1.2 bn, a placing by market volume, 40% dilution. Potential arbitrage opportunities. TP is 728p (5.3x EV/2023e EBITDA).
SUMMARY
(Sign Up to Access)
Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
Unlock all research summaries
Follow top, independent analysts
Receive personalised alerts and emails
Access Briefings, Analytics, and Events
Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.
Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.